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Abstract The p53 transcription factor is a key tumor sup-
pressor and a central regulator of the stress response, which
has been a subject of intense research for over 30 years.
Recently, a zebrafish line which carries splice site mutation
(G>T) in intron 8 of p53 gene (p53hu888), encoding the p53
paralogue, was developed (The Zebrafish Mutation Project).
To uncover molecular effects of the mutation, we raised hu888
zebrafish line to adulthood and analyzed DNA, mRNA data,
and protein levels of p53 to assess their potential contribution
in molecular mechanisms of the mutant fish. To obtain
zebrafish individuals homozygous for the point mutation,
p53hu888 carriers were repeatedly incrossed but only hetero-
zygous mutants (p53hu888/+) or p53-wild type hu888 zebrafish
(p53+/+) were identified in their progeny. By evaluation of
p53 expression changes in the liver of mutant and wild type
hu888 zebrafish as well as of Tübingen reference strain, we
demonstrated that two types of splicing occurred in each case:
a classical one and the alternative splicing which involves the
activation of cryptic splice-acceptor site in the exon 9 of
zebrafish p53 pre-mRNA. The alternative splicing event re-
sults in a deletion 12 nucleotides in the mature mRNA, and
produces a shortened variant of p53 protein. Interestingly,
expression of p53 protein in liver of both heterozygous and
wild type hu888 zebrafish was highly reduced compared to
that in the reference strain.
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Introduction
The growing number of forward and reverse genetic tools that
are available for zebrafish have successfully identified and
characterized many genes involved in development and dis-
eases. Functional knockout lines have expanded the experi-
mental power of the zebrafish genome to provide insight into
how orthologous mammalian genes function in similar pro-
cesses (Goodale et al. 2012). One of the most extensively
studied genes is the p53 tumor suppressor gene. Since its
discovery in 1979, the role of p53 protein in cancer has been
studied intensively (Levine and Oren 2009). The p53 protein
acts primarily as a transcription factor that regulates the ex-
pression of many different genes in response to a wide variety
of stress signals (Beckerman and Prives 2010; Lane 1992).
The significance of p53 in cancer is underscored by the fact
that it is the most frequently mutated tumor suppressor gene in
human cancers, with more than half of solid tumors harboring
mutations in the p53 locus (Olivier et al. 2010). All mutations
in the p53 gene found in human cancers are compiled by the
International Agency for Research on Cancer (IARC TP53
Database, http://www-p53.iarc.fr/) (Petitjean et al. 2007).
In humans, p53 is a 393 amino-acid protein composed of
several domains: an N-terminal transactivation domain
(TAD), a proline-rich domain (PRD), a large DNA binding
domain (DBD), a tetramerization domain (4D), and a C-
terminal regulatory domain (CTD). Nuclear export sequence
(NES) signals exist on both the N- and C-terminals, whereas
nuclear localization (NLS) signals are located on the C-
terminal region (Fig. 1a). Interestingly, a high degree of con-
servation in the structure and function of p53 protein exists
between distantly related organisms, such as fish and mam-
mals (Brzuzan et al. 2009; Chen et al. 2009), reptiles and
mammals (Soussi et al. 1987), and birds andmammals (Soussi
et al. 1988). For example, the full-length amino acid sequence
of zebrafish p53 is 48 % identical to human p53 (Cheng et al.
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1997) and retains all important domains reported for humans,
such as TAD, DBD, NLS, 4D, and CTD (Fig. 1b). Similarly,
the Xenopus laevis p53 protein reveals a high degree of
homology with the human (51 %) p53 amino acid sequence.
Furthermore, five highly conserved internal regions were
found in this protein (Soussi et al. 1987). The amino acid
sequence of chicken p53 shows 47 % homology with human
p53 (Soussi et al. 1988).
The principal mode of p53 alteration in human cancers are
single-base substitutions in the p53 coding sequence, leading
to missense mutations, nonsense mutations or frameshifts
(Olivier et al. 2010). More than 70 % of p53 mutations are
missense mutations affecting residues within DNA binding
domain. In contrast, mutations in non-coding regions of p53
have not been the subject of extensive study as compared to
those performed on exons. In particular, mutations in intronic
sequences which affect splicing sites, may potentially result in
truncated protein products or reduced protein levels. To date,
29 different p53 splice site mutations have been described in
various types of cancers (Holmila et al. 2003). For example,
an A>G transition in intron 10 that eliminates a splicing
acceptor site and causes a frameshift mutation, was recently
reported in a pediatric adrenocortical tumor (Pinto et al. 2011).
In recent years, it has become possible to generate numer-
ous mutations in various zebrafish genes, to illuminate func-
tional diversity of multiple phenotypes. Since launching of the
Zebrafish Genome Sequencing Project in 2001, the Sanger
Institute (http://www.sanger.ac.uk/) has played the lead role in
sequencing the zebrafish genome, mapping variants,
generating mutants, and characterizing them. A project
called The Zebrafish Mutation Project (ZMP), which aims to
create a knockout allele in every protein-coding gene in the
zebrafish genome, using a combination of whole exome en-
richment and Illumina next generation sequencing. So far,
11,892 genes have been mutated. Upon request, the ZMP
provides zebrafish embryos carrying point mutations in p53
gene. The available lines include embryos sa20404, sa20405,
sa114, or hu888. While the first two mutant zebrafish carry
nonsense mutations, the remaining two carry splice site mu-
tation (http://www.sanger.ac.uk/Projects/D_rerio/zmp/).
The experimental power of the zebrafish p53 mutant line
hu888 has been formerly indicated in the Zebrafish Mutation
Project, however it has not been previously evaluated. The
present study demonstrates the functional importance of this
mutation in the p53 gene in zebrafish. The p53hu888 zebrafish
mutants carry a mutation at position 25762707 of the chro-
mosome 5 (GenBank accession no: NC_007116). This muta-
tion is a substitution at the splice-acceptor site in the intron 8
of p53 gene (Fig. 1c); it can cause intron retention, skipping of
the succeeding exon or the use of a cryptic splice site, that is
present within the exon downstream of the splice-acceptor
site. Here, by evaluating sequencing data we demonstrated
that both the constitutive and the next available legitimate
splice site in exon 9 (the cryptic splice site) were used, and
that the alternative splicing event resulted in a deletion of 12
nucleotides in the mature mRNA. Together with the DNA and
mRNA data, we report protein levels of p53 in liver to assess




The zebrafish p53 mutants (p53hu888) were shipped from the
Derek Stemple Lab (Welcome Trust Sanger Institute, Cam-
bridge; UK). The delivered outcross stock (approx. 4 dpf
larvae; parental generation, the P-stock) was obtained from
spawning heterozygous mutant fish (p53hu888/+) with the
Fig. 1 Scheme of the human (a)
and the zebrafish (b) p53 gene
structure: an N-terminal
transactivation domain (TAD), a
proline-rich domain (PRD), a
large DNA binding domain
(DBD), a tetramerization domain
(4D), a C-terminal regulatory
domain (CTD), a nuclear export
signal (NES), a nuclear
localization signal (NLS), a
bipartite nuclear localization
signal (BNLS). Amino acid
numbers for functional domains
are indicated. (c) The p53hu888
zebrafish line has a G to T point
mutation at the splice-acceptor
site in the intron 8 of p53 gene.
Numbers of constitutive exons are
indicated
116 J Appl Genetics (2015) 56:115–121
wild-type main line (p53+/+), thus theoretically the progeny
consisted of 50 % of mutation carriers and needed further
identification. The obtained larvae were kept in 1 L baby
tanks at 28.5 °C for their first 21 days and then raised in
20 L aquaria with aerated tap water at 28 °C and 14:10
photoperiod. The fish were fed 2-times a day with artificial
Artemia and fish feed micropellets (AZOO; UK); the fish
were maintained according to the procedures described in
The Zebrafish Book (Westerfield 2000). After reaching sexual
maturity (12 weeks), randomly selected individuals from the P
outcross stock were separated into individual 5 L aquaria prior
to the molecular identification.
PCR-based identification of mutation carriers (p53hu888)
Caudal fin clips excised from anesthetized zebrafish were
used for genomic DNA (gDNA) extraction with Genomic
Mini kit (A&A Biotechnology; Poland). Zebrafish p53 frag-
ment containing wild type (wt) or mutant allele (hu888), was
amplified using primers (Dr-p53-7266F: 5′-cag gaa aac tga
gga gag caa ctt-3′ and Dr-p53-7502R: 5′-aga tct cct cgc tgc
tgg-3′) that were positioned in 8 and 9 exon of zebrafish p53,
respectively (GenBank accession no: NC_007116). Each
PCR reaction contained 5 μL of 2X DreamTaq Green PCR
Master Mix (Fermentas; Canada), 0.5 μM of each (forward
and reverse) primer, 1 μL of gDNA as template, and nuclease-
free water to 10 μL of the final volume. The reaction was
performed in Master Cycler Gradient thermalcycler
(Eppendorf; Germany) with the following conditions: 95 °C
for 2 min, followed by 35 cycles of 95 °C for 30 s, 60 °C for
30 s, 72 °C for 30 s, and then 72 °C for 7 min. Amplified PCR
product were separated in 1.5 % agarose gel and stained with
ethidium bromide (EtBr) using standard protocol (Sambrook
and Russell 2001). Homogenous amplicons, visualized as
single bands of approximately 240 bp, were subjected to
sequencing procedure (Genomed; Poland).
Breeding of mutants for F1 generation
The heterozygous hu888 zebrafish (p53hu888/+) were used to
obtain offspring (F1) that theoretically should have consisted
of 25 % of wild-type fish, 50 % of heterozygotes, and 25 % of
hu888 homozygotes. For breeding purposes, modified meth-
od for low-level embryo production was used (Westerfield
2000). Briefly, 2 L plastic tanks with net instead of the bottom
(mesh φ 3 mm) were immersed in 20 L glass tanks with tap
water (28 °C and 14:10 photoperiod). During the experiment,
spawning of p53hu888/+ zebrafish was performed 14 times.
Heterozygous fish were mated in breeding tanks at a ratio of
1 male to 2 females. The day after spawning, 30 min after the
start of photoperiod, the zebrafish eggs were collected and
rinsed with egg water (60 mg of Instant Ocean salts per L of
distilled water (Westerfield 2000)). The mutant zebrafish
exhibited sporadic spawning activity but successful in vitro
fertilization. The average number of eggs laid per mating
event was 199 (Witkowski 2013). The obtained zebrafish
embryos (F1) were kept in 120 mm petri dish plates (25
embryos per dish) and sorted out for any coagulated eggs until
hatching, with daily exchange of egg water. For all but one
spawning the clutches were small (few individuals only) and
died soon after hatching. Pericardial edema and jaw
malformations occurred with higher incidence in some of
the hu888 clutches. The hatched larvae were maintained as
mentioned above. In one of the p53hu888/+ clutch only, 19
zebrafish (11 males, and 8 females) out of 112 hatched,
reached sexual maturity, and these fish (10-month old) were
further subjected to molecular identification of their genotype
using the same PCR-based method, as described above. Of the
19 zebrafish assayed, 12 were hu888 homozygotes (p53+/+)
and the remaining seven (five males and two females) were
heterozygous (p53hu888/+).
RNA extraction, reverse transcriptase PCR, cloning,
and sequence analysis
Total RNA from liver of wild type zebrafish (p53+/+; n=3)
and hu888 heterozygotes (p53hu888/+; n=3) was isolated using
Total RNA Mini isolation kit (A&A Biotechnology; Poland)
following the manufacturer’s protocol; homozygous mutants
were not identified in F1 progeny. As an additional control,
the total RNA was isolated also from liver of wild type
Tübingen zebrafish strain (“T” p53+/+; n=3) (Max-Planck
Institute; Germany). The RNAwas further treated with DNase
I (Fermentas; Canada) to remove gDNA. The quality and
quantity of the mRNA samples were measured using the
Bioanalyzer 2100 (Agilent; USA). The DNase- treated RNA
was converted to cDNA using the Revert Aid First Strand
cDNA Synthesis Kit and oligo-dT primer (Fermentas; Cana-
da). The cDNAwas then used as a template for amplification
of p53 fragments using 12.5 μL of DreamTaq Green PCR
Master Mix (Fermentas; Canada), 0.5 μM of each primer (Dr-
p53-7266F, Dr-p53-7502R), 2 μL of cDNA as template, and
nuclease-free water to 25 μL of the final volume. The PCR
reaction was performed in Master Cycler Gradient
thermalcycler (Eppendorf; Germany) by using the following
thermal cycling program: initial denaturation at 95 °C for
3 min; 35 cycles consisting of denaturation at 94 °C for
30 s, annealing at 60 °C for 30 s, and amplification at 72 °C
for 30 s; and a final 7-min hold step at 72 °C. The correspond-
ing controls lacking reverse transcriptase or template RNA
were included for each reaction to confirm the absence of
genomic DNA. PCR products were separated by electropho-
resis (6.2 V/cm for 2 h) in 3 % low melting agarose gel
containing EtBr. Furthermore, separated amplicons (visual-
ized as single bands at respective lengths of 152 and 164 bp)
were excised from the gel, then melt at 50 °C and used in
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reamplification using the same PCR components and thermal
conditions. Reamplified PCR products were cloned into
pTZ57R/T vector using InsTAclone PCR Cloning Kit (Ther-
mo Scientific; Canada) according to the manufacturer’s rec-
ommendations. At least two independent clones of each
amplicons were sequenced in both directions (Genomed; Po-
land). Amplified PCR products were sequenced to reveal
splicing events of zebrafish p53.
Size determination of the different PCR products
corresponding to p53 variants
Each cDNA sample was also amplified using a forward primer
labeled at 5′ end with 6FAM dye (Dr-p53-7267F_FAM (5′-
gaa aac tga gga gag caa ctt-3′) from Applied Biosystems; UK,
and Dr-p53-7502R (5′-aga tct cct cat cgc tgc tgg-3′) (for PCR
conditions see above). Lengths of PCR fragments were deter-
mined using an Applied Biosystems 3130 Genetic Analyser
sequencer against GeneScan 500[LIZ] (Life Technologies,
USA) size standard. The separation of PCR product was
performed in capillary array at length of 36 cm and POP7
polymer following to manufacture’s recommendations. The
product’s size determination was performed using Data Col-
lection 3.0 software and GeneMapper 4.0 software (Life
Technologies; USA), following the manufacturer ’s
recommendations.
SDS-PAGE and western blot analysis
Livers from wild type zebrafish (p53+/+), wild type Tübingen
zebrafish strain (“T” p53+/+) and hu888 heterozygotes
(p53hu888/+) (n=3 in each group) were lysed in RIPA buffer
containing protease inhibitor cocktail set (Calbiochem; USA).
Lysates were centrifuged at 10,000 g for 20 min at 4 °C to
remove cell debris and insoluble proteins. After centrifuga-
tion, the supernatant was transferred into a chilled Eppendorf
tube. Protein extract were quantified by Bradford assay and
equal amounts (20 μg) of protein was separated by a 10 %
SDS-PAGE. After electrophoresis, the proteins were
electrotransferred onto a PVDF membrane (Sigma Aldrich;
USA) using a Mini Trans-Blot electrophoretic transfer cell
(Bio-Rad; USA) at 200 mA for 1 h. Nonspecific protein
binding was blocked with 5 % BSA in 1X TBST (50 mM
Tris–HCl pH 7.4, 150 mMNaCl, 0.1 % Tween 20) for 1.5 h at
room temperature. The membrane was then incubated over-
night at 4 °C with rabbit anti-zebrafish p53 antibody (#55342,
Anaspec, San Jose; CA), and subsequently incubated with
HRP-conjugated goat anti-rabbit IgG antibody (Cell Signal-
ing; USA) for 1 h at room temperature. The blots were
subsequently probed with anti-actin antibody (sc-1616-R,
Santa Cruz Biotechnology; USA) to assess protein loading.
All antibodies were diluted in 1X TBST at a concentration
1:1000. Antibody labeling was identified using 4-chloro-1-
naphthol/3,3 ́- diaminobenzidine tetrahydrochloride (CN/
DAB, Thermo Scientific; Canada) as substrates.
Results and discussion
The hu888 zebrafish line was established under the Zebrafish
Mutation Project with G to T point mutation at the splice-
acceptor site in the intron 8 of p53 gene, likely rendering the
mutant p53 gene a target of alternative splicing (Fig. 1c). Only
wild type zebrafish (p53+/+) and fish bearing a single mutant
hu888 allele (heterozygotes; p53hu888/+) survived to adult-
hood, with no consistently observed abnormalities during
development. The lack of survival of homozygous hu888
carriers is intriguing and suggest functional insufficiency of
resulting p53 phenotype during development. Further studies
should focus on cellular effects caused by aberrant proteins
encoded by the pair of two defective alleles. Fin
malformations were observed sporadically in some adult fish,
but did not appear to cause significant morbidity. The hetero-
zygous hu888 zebrafish was characterized by occasional
spawning activity, successful in vitro fertilization but high
larval mortality; most of the hatched zebrafish did not survive
48 h after the hatching. Although, the above characteristics
may suggest that the single hu888 mutation does not prevent
reproductive function in this line, irregular spawning may
indicate deficits in reproductive physiology or behavior.
Splice site mutations constitute the most common cause for
alternative splicing. Splicing occurs in several steps and is
catalyzed by small nuclear ribonucleoproteins (snRNPs). The
three sequence elements that direct this RNA processing in-
clude a donor site (5′ end of the intron) with an almost
invariant sequence GU, a branch site (near the 3′ end of the
intron) and an acceptor site (3′ end of the intron) includes an
almost invariant dinucleotide AG. First, the 5′ splice site is
cleaved and the 5′ end of the intron is joined to conserved
branch site to form a looped structure known as a lariat. The
first 9 nt of the 5′ end of the snRNP called U1 is complemen-
tary to the consensus sequence 5′-C(or A)AG GU(A)(or G)
AGU-3′ (natural 5′ splice site sequences usually deviate from
this consensus sequence at two or three positions) (Clancy
2008). Base pairing of the U1 snRNP and the mRNA is
essential for splicing. The G>T mutation at the splice-
acceptor site causes a mismatch with the 3′ end of the U1
snRNP. This type of mutation can lead to intron retention,
skipping of the succeeding exon, or activation a nearby cryptic
splice-acceptor site, that is present within the coding region.
The cryptic splice-acceptor site is located presumably by a
scanning mechanism that initiates at the branch site and pro-
ceeds in a 3′ direction to the first AG pair (Smith et al. 1993).
To find out whether G>T substitution at the splice-acceptor
site in the intron, between exon 8 and exon 9 of the p53
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(Figs. 1c and 2a), influenced the processing of the RNA
transcript, we performed reverse transcriptase-polymerase
chain reaction (RT-PCR) on total cDNA, prepared from
liver from two wild type zebrafish line (“T” p53+/+ and
p53+/+) and from mutant zebrafish (p53hu888/+). Gel elec-
trophoresis of resulting PCR products showed two
amplicons differing in length (Fig. 2b and c). The longer
amplicon of about 164 bp corresponds with a predicted
PCR product resulting from constitutive mRNA splicing,
whereas the shorter amplicon of about 152 bp was appar-
ently a result of alternative splicing. Sequencing of the
shorter amplicon revealed that a cryptic splice-acceptor
site within exon 9 was used, resulting in the deletion of
12 nt from the 5′ end of exon 9 in the p53 mRNA (Fig. 2d),
and the sequence of the cryptic splice-acceptor site was
AAG|AAUC.
Interestingly, the constitutive (164 bp) and alternative
(152 bp) splice variants of p53 gene were present in two wild
type zebrafish line and in mutant hu888 zebrafish (Fig. 2b and
c), but differed in the amount of the respective splice variant:
while constitutive splicing within intron 8 occurred more
frequently in p53 wild type lines (Tübingen, hu888) than
activation a cryptic splice site in exon 9, the alternative splic-
ing was a predominant process in heterozygous zebrafish
(p53hu888/+). This proves that cryptic splice sites are used not
only when a constitutive splice site is disrupted by a mutation.
In human, spliced isoforms are frequently regulated in a
developmental or tissue-dependent manner (Wang et al.
2008; Xu et al. 2002). Moreover changes in the ratios of
isoforms have been associated with physiological variation
in mammals and their susceptibility to disease (Chisa and
Burke 2007; Cooper et al. 2009). Therefore, further research
Fig. 2 Expression of p53
splicing variants in hu888
zebrafish line. (a)
Electropherograms of DNA
sequences spanning regions of the
G/T mutation (K). (b) Agarose
gel electrophoresis of RT-PCR
amplification of mRNA from
liver of two wild type zebrafish
line and p53hu888 zebrafish
mutant (heterozygous). Primers
Drp53- 7266F and Dr-p53-7502R
were used. Lane “T” p53:
amplicon of the mRNA expressed
from the liver of wild type
Tübingen zebrafish strain, lane
p53: amplicons of the mRNA
expressed from the liver of wild
type Sanger zebrafish strain, lane
p53hu888/+: amplicons of the
mRNA expressed from the liver
of p53hu888 zebrafish mutant
(heterozygous). Normally spliced
mRNAyielded a 164-bp
amplicon, whereas the alternative
splicing resulted in a 152-bp
amplicon. (c) Expression
intensities of p53 splice isoforms
in liver of two wild type zebrafish
line and p53hu888/+ zebrafish (blue
peaks); size standard GS 500LIZ
(orange peaks). (d) Splicing
mechanism using a normal splice
site (above). The resulting
product corresponds to the bands
of 164 bp. Alternative splicing
mechanism using a cryptic splice
sites (below), owing to mutations
at splice-acceptor site G>T
(marked in red). In case of this
abnormal splicing pathway 12 nt
are deleted from downstream of
exon 9. The resulting product
corresponds to the bands of 152
bp
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should focus on tracing co-occurrence of the two splice vari-
ants in zebrafish during development which may shed light on
mechanisms regulating expression of p53 isoforms in
vertebrates.
Besides full-length p53 protein, various p53 isoforms are
produced by alternative splicing, alternative promoter or co-
don initiation usage, or combinations thereof (Marcel et al.
2011). The resulting proteins differ from canonical, full-length
p53 protein, by truncation of a variable portion of the N-
terminus (ΔN isoforms) and by alternative C-terminal por-
tions (C-terminal isoforms) (Bourdon et al. 2005; Marcel et al.
2011). So far, at least 12 different p53 human protein isoforms
have been identified (Khoury and Bourdon 2010). The differ-
ential expression of several of these isoforms has recently
been established in cancer (Bourdon 2007; Wei et al. 2012)
though their functional role is not fully understood. To date, in
zebrafish only N-terminal p53 isoforms have been identified:
Zp53, corresponding to the human p53 protein (Cheng et al.
1997), ZΔNp53 produced through an alternative splicing of
intron-2 (Davidson et al. 2010) and ZΔ113p53, produced by
an internal promoter located within the zebrafish p53 gene that
is regulated by p53 itself (Chen et al. 2005).
Deletion of 12 nucleotides from a mature p53 mRNA, as a
consequence of G>T substitution at splice site, results in four
amino acid removal in the encoded zebrafish protein, from
leucine-278 to glutamic acid-281 and with replacement serine
by lysine at 277 position (Fig. 3) without changing the reading
frame. Further bioinformatics analysis of the isoform localized
the deletion to a domain specifying a putative bipartite nuclear
localization signal (BNLS) (Fig. 1b and c). Bipartite localiza-
tion signal controls the p53 protein shuttling between the
cytoplasm and the nucleus which is crucial for its tumor
suppressive activity (Sionov et al. 2001) and it has been found
that point mutations in the p53 NLS can severely reduce
activity of p53 nuclear import (O’Keefe et al. 2003). To find
out if zebrafish having partially deleted domain in putative
BNLS of the p53 isoform (p53hu888/+) exhibits abnormal p53
expression we examined the p53 levels in livers of the three
zebrafish lines. The observation of both, p53hu888 mutant and
p53 wild type hu888 zebrafish having highly reduced levels of
p53 in liver compared to wild type Tübingen strain (Fig. 4),
excluded the possibility that hu888 mutation itself is respon-
sible for the apparent reduction effect. One explanation for the
faint bands of p53 observed in hu888 zebrafish could be the
inability of the antibody to recognize the mutant isoform as a
result of truncation in the p53. To demonstrate a consequence
of the loss of nuclear localization, assay of the expression of
transcriptional targets of p53, such as p21, should be per-
formed (e.g., Rose et al. 2003). Additionally, cellular experi-
ments in which tagged constructs of the truncated version are
injected into zebrafish would probably clarify this issue
(Rosen et al. 2009). It is also likely that the mutant line
hu888 carries other mutations throughout the p53 gene, which
result in aberrant expression (attenuation) of p53 protein,
however further studies are necessary to clarify this issue.
The above data suggest that intronic G>T mutation has
little effect on the reduction of a cell’s overall p53 concentra-
tion in heterozygous zebrafish, and it is unlikely that it signif-
icantly disturbs p53 function under normal conditions. It
remains unknown however, what effect the aberrant p53 pro-
tein may have on successful executing defense programs in
response to cell physiological signals typically provoking p53
increases. The G>T transversion, and other mutations, in p53
gene of hu888 zebrafish line may be considered dominant
negative (dn) mutations whose altered gene products act an-
tagonistically to the wild-type allele (Goh et al. 2011). The
p53 protein normally functions as a homotetrameric transcrip-
tion factor. However, in cells bearing a single mutant p53
Fig. 3 Clustal X alignments of two p53 splicing products obtained in this study. The nucleotide sequences of p53 amplicons from both wild type
(p53+/+) and p53hu888 zebrafish. TheRT-PCRprimers are indicated by arrows. The amino acid sequence of zebrafish is shown (NCBI: NP_001258749.1)
Fig. 4 Representative Western blot results fromWestern blot analysis of
p53 expression in two wild type zebrafish lines and p53hu888/+ mutant.
Actin was used as the loading control. “T” p53: wild type Tübingen
zebrafish strain; p53: wild type Sanger zebrafish strain; p53hu888/+:
p53hu888 zebrafish mutant (heterozygous)
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allele that codes for a structurally altered protein, the mutant
protein may retain its ability to form tetramers but may lose its
ability to exert normal function. Consequently, mixed tetra-
mers composed of differing proportions of wild-type and
mutant p53 subunits may form, and thus may compromise
the functioning of the entire tetramer; in a cell that is hetero-
zygous at the p53 locus, like that in hu888 zebrafish line, as
many as 15 of 16 of the subunits may lack fully normal
functions. Therefore, future experiments on the hu888
zebrafish line are needed to resolve how the p53 mutant
isoforms interfere with wild type p53. This would allow to
gain further insight into role of the p53 isoforms in embryo
development, cancer and aging.
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